Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03QZB
|
||||
Former ID |
DIB012733
|
||||
Drug Name |
F-1394
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arteriosclerosis [ICD9: 440; ICD10:I70] | Discontinued in Phase 1 | [545396] | ||
Company |
Fujirebio KK
|
||||
Structure |
Download2D MOL |
||||
Formula |
C33H61N3O6
|
||||
Canonical SMILES |
C(=O)(N[C@@H]1[C@@H](OC(=O)CCNC(=O)[C@@H]2OC(OCC2(C)C)(<br />C)C)CCCC1)N(CC(C)(C)C)CCCCCCCCC
|
||||
CAS Number |
CAS 162490-89-3
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Modulator | [526020] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.